The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Accuracy of screening for gastric cancer using serum pepsinogen concentrations
Open accessAbstract
BACKGROUND/AIMS: The characteristics of pepsinogen screening for gastric cancer were investigated to establish a suitable cut off point for identifying gastric cancer, using endoscopic diagnosis as the yardstick. SUBJECTS/METHODS: Serum pepsinogen concentrations were measured in 5113 subjects who were also screened for gastric cancer by endoscopy. The cut off point for pepsinogen was determined using receiver operator characteristics curves. RESULTS: The most suitable cut off point was a pepsinogen I concentration of less than 70 ng/ml and a ratio of pepsinogen I to pepsinogen II of less than 3.0. Using this cut off point, the sensitivity and specificity of pepsinogen screening for gastric cancer were 84.6% and 73.5% respectively. All cases of gastric cancer in patients with severe atrophic gastritis were detected. However, two of four cases of gastric cancer in patients with mild atrophic gastritis were overlooked. In subjects with mild atrophic gastritis, when gastric cancer arises within the fundic gland region, the size of the lesion determines whether it is possible to detect cancer by serum pepsinogen screening. CONCLUSION: Pepsinogen screening has many advantages, including its suitability for combination with other screening methods because it is simple and inexpensive.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relationships Among Serum Pepsinogen I, Serum Pepsinogen II, and Gastric Mucosal Histology
Samloff, I. M., Varis, K., Ihamaki, T., Siurala, M., & Rotter, J. I. (1982) · Gastroenterology · doi:10.1016/0016-5085(82)90176-7 · Cited by 414
Cited by
Pimentel-Nunes, P., Libânio, D., Marcos-Pinto, R., Areia, M., Leja, M., Esposito, G., Garrido, M., Kikuste, I., Megraud, F., Matysiak-Budnik, T., et al. (2019) · Endoscopy · doi:10.1055/a-0859-1883 · Cited by 993
Dinis-Ribeiro, M., Areia, M., de Vries, A., Marcos-Pinto, R., Monteiro-Soares, M., O’Connor, A., Pereira, C., Pimentel-Nunes, P., Correia, R., Ensari, A., et al. (2012) · Endoscopy · doi:10.1055/s-0031-1291491 · Cited by 680
Gastric cancer: Prevention, screening and early diagnosis
Pasechnikov, V. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i38.13842 · Cited by 436
The Japanese Guidelines for Gastric Cancer Screening
Hamashima, C., Shibuya, D., Yamazaki, H., Inoue, K., Fukao, A., Saito, H., & Sobue, T. (2008) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyn017 · Cited by 403
Watabe, H., Mitsushima, T., Yamaji, Y., Okamoto, M., Wada, R., Kokubo, T., Doi, H., Yoshida, H., Kawabe, T., & Omata, M. (2005) · Gut · doi:10.1136/gut.2004.055400 · Cited by 401
Asia–Pacific consensus guidelines on gastric cancer prevention
Fock, K. M., Talley, N., Moayyedi, P., Hunt, R., Azuma, T., Sugano, K., Xiao, S. D., Lam, S. K., Goh, K. L., Chiba, T., et al. (2008) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05314.x · Cited by 354
S3-Leitlinie „Magenkarzinom” -
Moehler, M., Al-Batran, S.-E., Andus, T., Anthuber, M., Arends, J., Arnold, D., Aust, D., Baier, P., Baretton, G., Bernhardt, J., et al. (2011) · Zeitschrift für Gastroenterologie · doi:10.1055/s-0031-1273201 · Cited by 283
Gastric cancer screening using the serum pepsinogen test method
Miki, K. (2006) · Gastric Cancer · doi:10.1007/s10120-006-0397-0 · Cited by 275
Diagnosis and Management of High Risk Group for Gastric Cancer
Yoon, H., & Kim, N. (2015) · Gut and Liver · doi:10.5009/gnl14118 · Cited by 262
Metadata
- Authors
- Kitahara, F., Kobayashi, K., Sato, T., Kojima, Y., Araki, T., & Fujino, M. A.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 1999-05-01
- Volume
- 44
- Issue
- 5
- Pages
- 693-697
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2114348562
- Cited by
- 233
- References
- 1
- FWCI
- 3.57
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.